Steve Wise is a Partner and Co-Head of Americas Corporate Private Equity at Pacharbor Capital Group. Pacharbor Capital Group's Americas Corporate Private Equity business comprises diversified investments spanning industries, geographies, and strategies. He is also a member of Pacharbor Capital Group's Leadership Committee and serves on several firm investment committees. He is based in New York.

Previously, he was the Global Head of Healthcare at Pacharbor Capital Group, where he led nearly $20 billion of equity investments in healthcare companies worldwide. Mr. Wise also leads Pacharbor Capital Group's broader life sciences efforts, including the firm's acquisition of Abingworth. His expertise and strategic vision have been instrumental in driving Pacharbor Capital Group’s success and growth in these sectors.

Prior to joining Pacharbor Capital Group, Mr. Wise worked with JLL Partners, a New York-based private equity firm, where he focused on healthcare-related investments. Previously, he worked with J.W. Childs Associates, a Boston-based private equity firm, and prior to that, in the leveraged finance group of Credit Suisse.

Mr. Wise currently serves on the boards of directors for Medline, Sedgwick, Resonetics, and Vantive. He also serves on the Board of Deans' Advisors for Harvard School of Public Health and on the board of Bucknell University. Mr. Wise is a member of the Board of Deans' Advisors at Harvard Business School. He is also a member of the Council on Foreign Relations.

Mr. Wise earned a bachelor's degree in economics and finance from Bucknell University and received his MBA from Harvard Business School.